This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe
1-3 December 2025
Mercure Hotel MOABerlin, Germany
Book Now
Menu
Book

Ángel Lucio Pereira
Chief Executive Officer at Tetraneuron
Speaker

Profile

Ángel Lucio is CEO of Tetraneuron, a biotechnology company breaking barriers in neuroscience by developing gene therapies with the potential to reverse Alzheimer’s disease. With 17+ years of international leadership at Johnson & Johnson, Takeda, Reckitt and Sanofi, he brings a unique blend of scientific insight, business development and M&A expertise. Passionate about transforming neurodegeneration treatment, he drives Tetraneuron’s mission to deliver the first disease-modifying therapies for patients worldwide.

Agenda Sessions

  • A Disruptive Gene Therapy Platform to Reverse Neurodegeneration

    , 15:15
    View Session

At this event

Prev
Next
Dethardt Müeller
Chief Technology Officer - CMC
Abalos Therapeutics GmbH

See Ángel at Cell & Gene Therapy International Europe

Book Now